# | Title | Journal | Year | Citations |
---|
1 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation | Heart Rhythm | 2017 | 1,671 |
2 | Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement | Journal of Cardiovascular Magnetic Resonance | 2013 | 864 |
3 | A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD) | European Heart Journal | 2014 | 848 |
4 | Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis | Circulation | 2010 | 793 |
5 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation | Europace | 2018 | 767 |
6 | Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases | European Heart Journal | 2016 | 757 |
7 | Recommendations for interpretation of 12-lead electrocardiogram in the athlete | European Heart Journal | 2010 | 730 |
8 | Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease | Journal of the American College of Cardiology | 2015 | 662 |
9 | Left-Dominant Arrhythmogenic Cardiomyopathy | Journal of the American College of Cardiology | 2008 | 590 |
10 | Evaluation of Techniques for the Quantification of Myocardial Scar of Differing Etiology Using Cardiac Magnetic Resonance | JACC: Cardiovascular Imaging | 2011 | 514 |
11 | Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression | Circulation | 2007 | 491 |
12 | Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator | Journal of the American College of Cardiology | 2015 | 458 |
13 | Management of Grown Up Congenital Heart Disease | European Heart Journal | 2003 | 446 |
14 | Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis | Circulation | 2015 | 442 |
15 | Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Is a Fully Penetrant, Lethal Arrhythmic Disorder Caused by a Missense Mutation in the TMEM43 Gene | American Journal of Human Genetics | 2008 | 431 |
16 | Natural history and familial characteristics of isolated left ventricular non-compaction | European Heart Journal | 2005 | 427 |
17 | Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry | European Heart Journal | 2014 | 410 |
18 | How to develop a more accurate risk prediction model when there are few events | BMJ, The | 2015 | 405 |
19 | Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 Mapping | Circulation: Cardiovascular Imaging | 2013 | 399 |
20 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary | Europace | 2018 | 375 |
21 | Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? | European Heart Journal | 2007 | 370 |
22 | Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy | European Heart Journal | 2006 | 352 |
23 | 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary | Journal of Arrhythmia | 2017 | 348 |
24 | Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases | European Heart Journal | 2013 | 346 |
25 | Native T1 Mapping in Transthyretin Amyloidosis | JACC: Cardiovascular Imaging | 2014 | 339 |
26 | Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume | Circulation: Cardiovascular Imaging | 2013 | 324 |
27 | Myocardial reperfusion injury: looking beyond primary PCI | European Heart Journal | 2013 | 318 |
28 | Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial† | European Journal of Cardio-thoracic Surgery | 2013 | 317 |
29 | T1 mapping and survival in systemic light-chain amyloidosis | European Heart Journal | 2015 | 310 |
30 | Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease) | Heart Rhythm | 2004 | 309 |
31 | Aetiology and management of chylothorax in adults | European Journal of Cardio-thoracic Surgery | 2007 | 283 |
32 | Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease | Heart | 2012 | 276 |
33 | Effects of enzyme replacement therapy on the cardiomyopathy of Anderson Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa | Heart | 2008 | 269 |
34 | Quantification of Myocardial Extracellular Volume Fraction in Systemic AL Amyloidosis | Circulation: Cardiovascular Imaging | 2013 | 261 |
35 | Intravenous Iron Alone for the Treatment of Anemia in Patients With Chronic Heart Failure | Journal of the American College of Cardiology | 2006 | 260 |
36 | Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review | Heart | 2014 | 248 |
37 | Percutaneous Implantation of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position | Journal of the American College of Cardiology | 2011 | 239 |
38 | Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy | Heart | 2005 | 235 |
39 | The impact of the coronary collateral circulation on mortality: a meta-analysis | European Heart Journal | 2012 | 224 |
40 | Pulmonary Regurgitation Is an Important Determinant of Right Ventricular Contractile Dysfunction in Patients With Surgically Repaired Tetralogy of Fallot | Circulation | 2004 | 223 |
41 | Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy | European Heart Journal | 2012 | 220 |
42 | Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI | Journal of Cardiovascular Magnetic Resonance | 2013 | 216 |
43 | Myotonic dystrophy: time for evidence-based therapy | European Heart Journal | 2014 | 211 |
44 | A Novel Dominant Mutation in Plakoglobin Causes Arrhythmogenic Right Ventricular Cardiomyopathy | American Journal of Human Genetics | 2007 | 208 |
45 | Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy | Journal of the American College of Cardiology | 2007 | 207 |
46 | Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR | Journal of Cardiovascular Magnetic Resonance | 2012 | 207 |
47 | Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial | Heart | 2009 | 205 |
48 | Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing | Journal of Medical Genetics | 2013 | 203 |
49 | How Does the Ascending Aorta Geometry Change When It Dissects? | Journal of the American College of Cardiology | 2014 | 201 |
50 | Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial | Lancet Respiratory Medicine,the | 2015 | 199 |